Keyphrases
Mesoporous Silica Nanoparticles
100%
Controlled Release
100%
Pentamidine
100%
Cancer Treatment
8%
Functional Groups
8%
Myotonic Dystrophy
8%
Nephrotoxicity
8%
Systemic Administration
8%
Aminopropyl
8%
In Vitro Evaluation
8%
Base-free
8%
Functionalized Mesoporous Silica Nanoparticles
8%
Kinetic Release
8%
Pentamidine Isethionate
8%
High Loading Capacity
8%
Antiprotozoal Agents
8%
Loading Experiment
8%
Pharmacology, Toxicology and Pharmaceutical Science
Controlled Release
100%
Mesoporous Silica Nanoparticle
100%
Pentamidine
100%
Malignant Neoplasm
7%
Functional Groups
7%
Nephrotoxicity
7%
Base
7%
Systemic Administration
7%
Pentamidine Isethionate
7%
Myotonic Dystrophy
7%
Antiprotozoal Agent
7%
Table Salt
7%
Chemistry
Mesoporous Silica
100%
Pentamidine
100%
Nanoparticle
100%
Base
7%
Pentamidine Isethionate
7%
Antiprotozoal Agent
7%
Table Salt
7%
Engineering
Controlled Release
100%
Silica Nanoparticle
100%
Functional Group
7%
Material Science
Mesoporous Silica
100%
Silica Nanoparticle
100%
Chemical Engineering
Nanoparticle
100%
Functional Group
7%